Pediatric Cancer and IHC Webinar

Webinar Duration: 60 minutes

 What Does it Cover?

Childhood cancer and pediatric cancer are general terms used to describe a wide range of neoplasms found in children and teenagers. Occurring in approximately 1 in 300 people under the age of 20, compared to 1 in 6 adults, pediatric cancers are more rare than adult cancers. Because less is known about pediatric cancers, diagnosis can be quite challenging for pathologists.

This presentation covers the basic science, as well as facts and statistics about pediatric cancer. We will discuss how the utility of immunohistochemical testing along with the application of novel antibodies can contribute to accurate diagnosis and survival rates of pediatric cancer patients.

Continuing education credits for attending this webinar will be offered through the National Society of Histotechnology.

 What Will You Learn?

  • The pathology of pediatric cancer
  • Innovative detection markers including CITED1, NKX2.2, Langerin, and PHOX2B
  • Demonstration of advanced staining on clinical samples

 Who Should Attend?

  • Pathologist
  • Lab Managers
  • Histotechnologists
Speaker Bio
Jeff Gordon
Director of OEM Sales
Cell Marque
• BS microbiology (University of Arkansas)
• 15 years of diagnostic IHC experience
• Over 25 NSH-approved workshops conducted
• Six trade show posters co-authored